Muscle Cells: Tailoring the taste of cultured meat

A new protocol can customize the flavor of lab-grown meat by controlling the level of fat deposited between muscle cells.
  1. Gyuhyung Jin
  2. Xiaoping Bao  Is a corresponding author
  1. Davidson School of Chemical Engineering, Purdue University, United States

Although the idea of growing meat in a laboratory may seem like science fiction, over a decade has passed since the first synthetic beef burger was unveiled in 2013 (Kupferschmidt, 2013). Moreover, in June 2023, two companies – Upside Foods and GOOD Meat – were granted approval by the Food and Drug Administration (FDA) to sell ‘cultured meat’ products in the United States (Wiener-Bronner, 2023).

While producing meat in a laboratory could eventually lead to a reduction in livestock farming, which would bring benefits in terms of improved animal welfare and reduced environmental impact (Post, 2012), the process is not free from challenges. For instance, there are concerns around food safety, the high cost of production, and whether the public will accept meat that has been artificially made. Also, if the cultured meat does not taste exactly like the real deal, consumers may turn away. Moreover, cultured meat products will have to compete against other, more affordable options, such as plant-based burgers.

A compelling advantage of cultured meat is that its texture, flavor and nutritional content can be tailored during production (Broucke et al., 2023). Lab-grown meat is made by isolating cells from the tissue of a live animal or fertilized egg, and differentiating them into muscle, fat and connective tissue. By altering the composition of cells generated during this process, researchers could make lab-grown meat that is personalized to an individual’s taste. However, combining and co-culturing the different source cells needed to produce these three components is no easy task. Now, in eLife, Hen Wang and co-workers – including Tongtong Ma, Ruimin Ren and Jianqi Lv as joint first authors – report an innovative approach for customizing cultured meat using just fibroblasts from chickens (Ma et al., 2024; Figure 1).

How cultured meat can be customized to enhance flavor.

First, fibroblasts were sourced from the fertilized eggs of chickens and grown on a flat surface. The cells were then implanted into a three-dimensional scaffold made up of hydrogel (grey cylinder with white dots), where they were differentiated into muscle cells. The differentiated fibroblasts were then supplemented with insulin and fatty acids to induce the deposition of fat between the muscle cells. The fat content of meat influences how it tastes and smells: by changing the amount of insulin and fatty acids, Ma et al. were able to produce cultured meat with low (beige), medium (light brown), or high (dark brown) levels of fat content.

Image Credit: Gyuhyung Jin (CC BY 4.0).

First, the team (who are based at Shandong Agricultural University and Huazhong Agricultural University) optimized the culture conditions for the chicken fibroblasts. This included changing the composition of the medium the cells were fed, and developing a three-dimensional environment, made of a substance called hydrogel, that the fibroblasts could grow and differentiate in. Ma et al. then used a previously established protocol to activate the gene for a protein called MyoD, which induces fibroblasts to transform into muscle cells (Ren et al., 2022). Importantly, the resulting muscle cells exhibited characteristics of healthy muscle cells and were distinct from muscle cells that appear during injury.

While muscle is a fundamental component of meat, the inclusion of fat and extracellular matrix proteins is essential for enhancing flavor and texture (Fraeye et al., 2020). To stimulate the formation of fat deposits between the muscle cells, the differentiated chicken muscle cells were exposed to fatty acids and insulin. This caused the cells to produce lipid droplets, signifying that the process of fat synthesis had been initiated. Measuring the level of the lipid triglyceride revealed that the fat content of the cultured fibroblasts was comparable to that in real chicken meat, and even climbed two to three times higher when insulin levels were increased.

Ma et al. then validated that the chicken fibroblasts were also able to produce various extracellular matrix proteins found in connective tissue. This is critical for forming edible cultured meat products as the tissue surrounding muscle cells gives meat its texture and structural integrity.

The study by Ma et al. underscores the potential for modulating key components (such as muscle, fat, and extracellular matrix proteins) to produce high quality lab-grown meat that is palatable to consumers. It also demonstrates how the important components of meat can be produced from just a single source of fibroblasts, rather than mixing multiple cell types together. As this is a proof-of-concept study, many of the issues associated with producing cultured meat for a mass market still persist. These include the high cost of components such as insulin, and concerns around the use of genetically modified cells: moreover, potentially toxic chemicals are required to activate the gene for MyoD.

Nevertheless, advancements in biotechnology, coupled with the recent FDA approval for genetically modified cells in lab-grown meat production (Martins et al., 2024), signal a promising future for the cultured-meat market. In the future, genetic, chemical and physical interventions may be used to precisely design other bioactive compounds found in meat, in addition to fat and muscle (Jairath et al., 2024). It may not be long until personalized cultured meat products with finely-tuned flavors, textures, and nutrients are available for sale.


Article and author information

Author details

  1. Gyuhyung Jin

    Gyuhyung Jin is in the Davidson School of Chemical Engineering, Purdue University, West Lafayette, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9141-1398
  2. Xiaoping Bao

    Xiaoping Bao is in the Davidson School of Chemical Engineering, Purdue University, West Lafayette, United States

    For correspondence
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0955-6868

Publication history

  1. Version of Record published: May 30, 2024 (version 1)


© 2024, Jin and Bao

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 389
  • 32
  • 0

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Gyuhyung Jin
  2. Xiaoping Bao
Muscle Cells: Tailoring the taste of cultured meat
eLife 13:e98918.

Further reading

    1. Cell Biology
    2. Developmental Biology
    Nicolas Loyer, Elizabeth KJ Hogg ... Jens Januschke
    Research Article

    The generation of distinct cell fates during development depends on asymmetric cell division of progenitor cells. In the central and peripheral nervous system of Drosophila, progenitor cells respectively called neuroblasts or sensory organ precursors use PAR polarity during mitosis to control cell fate determination in their daughter cells. How polarity and the cell cycle are coupled, and how the cell cycle machinery regulates PAR protein function and cell fate determination is poorly understood. Here, we generate an analog sensitive allele of CDK1 and reveal that its partial inhibition weakens but does not abolish apical polarity in embryonic and larval neuroblasts and leads to defects in polarisation of fate determinants. We describe a novel in vivo phosphorylation of Bazooka, the Drosophila homolog of PAR-3, on Serine180, a consensus CDK phosphorylation site. In some tissular contexts, phosphorylation of Serine180 occurs in asymmetrically dividing cells but not in their symmetrically dividing neighbours. In neuroblasts, Serine180 phosphomutants disrupt the timing of basal polarisation. Serine180 phosphomutants also affect the specification and binary cell fate determination of sensory organ precursors as well as Baz localisation during their asymmetric cell divisions. Finally, we show that CDK1 phosphorylates Serine-S180 and an equivalent Serine on human PAR-3 in vitro.

    1. Cancer Biology
    2. Cell Biology
    Mengya Zhao, Beiying Dai ... Yijun Chen
    Research Article

    Philadelphia chromosome-positive (Ph+) leukemia is a fatal hematological malignancy. Although standard treatments with tyrosine kinase inhibitors (TKIs) have achieved remarkable success in prolonging patient survival, intolerance, relapse, and TKI resistance remain serious issues for patients with Ph+ leukemia. Here, we report a new leukemogenic process in which RAPSYN and BCR-ABL co-occur in Ph+ leukemia, and RAPSYN mediates the neddylation of BCR-ABL. Consequently, neddylated BCR-ABL enhances the stability by competing its c-CBL-mediated degradation. Furthermore, SRC phosphorylates RAPSYN to activate its NEDD8 E3 ligase activity, promoting BCR-ABL stabilization and disease progression. Moreover, in contrast to in vivo ineffectiveness of PROTAC-based degraders, depletion of RAPSYN expression, or its ligase activity decreased BCR-ABL stability and, in turn, inhibited tumor formation and growth. Collectively, these findings represent an alternative to tyrosine kinase activity for the oncoprotein and leukemogenic cells and generate a rationale of targeting RAPSYN-mediated BCR-ABL neddylation for the treatment of Ph+ leukemia.